Sickle cell disease (or sickle cell anemia) is the most common genetic disease in France with 586 children screened in 2019. This chronic disease is characterized by the presence of abnormal Hemoglobin (Hb) S and a deformation of the red blood cells which take the elongated shape of a sickle and become more rigid and more fragile. Sickle cell disease manifests itself among other things by very painful vaso-occlusive crises (VOC) and for some chronic pain. Their management is an emergency and often requires hospitalization. Despite analgesic treatment, some patients have persistent pain. In 2013, a childcare assistant trained in Canadian global reflexology EMC offered reflexology sessions to 12 sickle cell patients. She observed a relief in all patients with a decrease in the pain score in 8 of them. These sessions seem to show us a double interest: the reduction of the child\'s pain and the emergence of a technique that can be used by paramedics in the context of their own role. The investgators hypothesize that global reflexology is an effective and acceptable complementary technique for pain management in addition to the usual analgesic management in sickle cell children under 18 years of age in CVO. In order to verify our hypothesis, the investigators propose to explore the practice of Canadian global reflexology as an innovative therapeutic option complementary to drug treatments in the hospital management of sickle cell children.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
30
The EMC method is a global reflexology technique inspired by the work of the American naturopath Stanley Burrough (Vitaflex, 1976). It is a method of reflexology on the whole body, of acupressure massages (rhythmic and targeted movements) on so-called \"reflex\" zones which is practiced on different areas of the body (feet, hands, arms, legs, collarbone, ear) and allows the stimulation of all systems.
Hôpital Femme Mère Enfant
Bron, France
RECRUITINGPain score T20 with the Face Legs Activity Cry Consolability scale
Evolution of pain scores (Face Legs Activity Cry Consolability - FLACC according to the child\'s age) T0 and T20 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the FLACC pain scale
Time frame: 20 minutes after the start of the session
Pain score T20 with the Visual Analog Scale
Evolution of pain scores (VAS - Visual Analog Scale according to the child\'s age) T0 and T20 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the VAS pain scale
Time frame: 20 minutes after the start of the session
Pain score T80 with the Visual Analog Scale
Changes in pain scores (VAS - Visual Analog Scale according to the child\'s age) at each session between T0 and T80 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the VAS pain scale
Time frame: 80 MINUTES after the start of the session
Pain score T80 with the Face Legs Activity Cry Consolability scale
Changes in pain scores (Face Legs Activity Cry Consolability according to the child\'s age) at each session between T0 and T80 minutes after the start of the sessionmn. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the FLACC pain scale
Time frame: 80 minutes after the start of the session
Length of hospitalization
Length of stay of patients included in the study, defined by the time between their entry into the UHCD or USC and their return home.
Time frame: 1 Month
Number of reflexology sessions
Total number of global reflexology sessions performed for each child included in the study.
Time frame: 1 Month
Recorded side effects, complications
Recorded side effects, complications
Time frame: 1 Month
Acceptability of the technique : refusal to participate.
Acceptability of the technique: number of refusals to participate in the protocol during the study.
Time frame: 25 Months
Acceptability of the technique: reason for refusal to participate.
Acceptability of the technique: reasons of refusals to participate in the protocol during the study.
Time frame: 25 months
Acceptability of the technique: interruption of participation.
Acceptability of the technique: number of requests for interruption during the study.
Time frame: 25 months
Acceptability of the technique: reason for interruption of participation
Acceptability of the technique: reasons for discontinuations for requests of interruption during the study.
Time frame: 25 months
Feasibility of the technique
Feasibility of the technique: integration into the management of CVO: number of sessions not performed or interrupted and reasons, duration of sessions.
Time frame: 25 months
Inclusion rate
Monthly inclusion rate in the study, characteristics of the eligible population, included and not included.
Time frame: 25 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.